Prognostic value of coronary vascular dysfunction assessed by rubidium-82 PET/CT imaging in patients with resistant hypertension without overt coronary artery disease
- PMID: 33594472
- PMCID: PMC8426234
- DOI: 10.1007/s00259-021-05239-w
Prognostic value of coronary vascular dysfunction assessed by rubidium-82 PET/CT imaging in patients with resistant hypertension without overt coronary artery disease
Abstract
Purpose: The identification of coronary vascular dysfunction may enhance risk stratification in patients with resistant hypertension (RH). We evaluated if impaired coronary vascular function, assessed by rubidium-82 (82Rb) positron emission tomography/computed tomography (PET/CT) imaging, is associated with increased cardiovascular risk in patients with hypertension without overt coronary artery disease (CAD).
Methods: We studied 517 hypertensive subjects, 26% with RH, without overt CAD, and with normal stress-rest myocardial perfusion imaging at 82Rb PET/CT. The outcome end points were cardiac death, nonfatal myocardial infarction, coronary revascularization, and admission for heart failure.
Results: Over a median of 38 months (interquartile range 26 to 50), 21 cardiac events (4.1% cumulative event rate) occurred. Patients with RH were older (p < 0.05) and had a higher prevalence of left ventricular hypertrophy (p < 0.001), a lower hyperemic myocardial blood flow (MBF), and myocardial perfusion reserve (MPR) (both p < 0.001) compared to those without. Conversely, coronary artery calcium content and baseline MBF were not different between patients with and without RH. At univariable Cox regression analysis, age, RH, left ventricular ejection fraction, coronary artery calcium score, and reduced MPR were significant predictors of events. At multivariable analysis, age, RH, and reduced MPR (all p < 0.05) were independent predictors of events. Patients with RH and reduced MPR had the highest risk of events and the major risk acceleration over time.
Conclusion: The findings suggest that the assessment of coronary vascular function may enhance risk stratification in patients with hypertension.
Keywords: Myocardial perfusion reserve; PET/CT; Prognosis; Resistant hypertension.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Coronary vascular function in patients with resistant hypertension and normal myocardial perfusion: a propensity score analysis.Eur Heart J Cardiovasc Imaging. 2019 Aug 1;20(8):949-958. doi: 10.1093/ehjci/jez025. Eur Heart J Cardiovasc Imaging. 2019. PMID: 30768182
-
Combined evaluation of regional coronary artery calcium and myocardial perfusion by 82Rb PET/CT in predicting lesion-related outcome.Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1698-1704. doi: 10.1007/s00259-019-04534-x. Epub 2019 Dec 14. Eur J Nucl Med Mol Imaging. 2020. PMID: 31836909
-
Relationship between epicardial adipose tissue and coronary vascular function in patients with suspected coronary artery disease and normal myocardial perfusion imaging.Eur Heart J Cardiovasc Imaging. 2019 Dec 1;20(12):1379-1387. doi: 10.1093/ehjci/jez182. Eur Heart J Cardiovasc Imaging. 2019. PMID: 31302673
-
Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health.JACC Cardiovasc Imaging. 2010 Jun;3(6):623-40. doi: 10.1016/j.jcmg.2010.04.007. JACC Cardiovasc Imaging. 2010. PMID: 20541718 Review.
-
Quantitative assessment of myocardial blood flow--clinical and research applications.Semin Nucl Med. 2014 Jul;44(4):274-93. doi: 10.1053/j.semnuclmed.2014.04.002. Semin Nucl Med. 2014. PMID: 24948151 Review.
Cited by
-
Assessment of Left Ventricular Shape Index and Eccentricity Index as Promising Parameters for Detection of Left Ventricular Remodeling in Cardiovascular Events.Curr Cardiol Rev. 2025;21(5):42-51. doi: 10.2174/011573403X357558250122062037. Curr Cardiol Rev. 2025. PMID: 39931848 Review.
-
Immediate recruitment of dormant coronary collaterals can provide more than half of normal resting perfusion during coronary occlusion in patients with coronary artery disease.J Nucl Cardiol. 2023 Dec;30(6):2338-2345. doi: 10.1007/s12350-023-03271-x. Epub 2023 Jun 6. J Nucl Cardiol. 2023. PMID: 37280387 Free PMC article.
-
Impact on cardiovascular outcome of coronary revascularization-induced changes in ischemic perfusion defect and myocardial flow reserve.Eur J Nucl Med Mol Imaging. 2024 May;51(6):1612-1621. doi: 10.1007/s00259-023-06588-4. Epub 2024 Jan 9. Eur J Nucl Med Mol Imaging. 2024. PMID: 38191816 Free PMC article.
-
Advanced imaging tools for evaluating cardiac morphological and functional impairment in hypertensive disease.J Hypertens. 2022 Jan 1;40(1):4-14. doi: 10.1097/HJH.0000000000002967. J Hypertens. 2022. PMID: 34582136 Free PMC article. Review.
-
Including myocardial flow reserve by PET in prediction models: Ready to fly?J Nucl Cardiol. 2023 Oct;30(5):2054-2057. doi: 10.1007/s12350-023-03259-7. Epub 2023 Apr 18. J Nucl Cardiol. 2023. PMID: 37072671 No abstract available.
References
-
- Carey RM, Calhoun D, Bakris G, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Genomic and Precision Medicine; Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Stroke Council et al. Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension. 2018;72(5):e53–e90. doi: 10.1161/HYP.0000000000000084. - DOI - PMC - PubMed
-
- Zampella E, Acampa W, Assante R, Nappi C, Gaudieri V, Mainolfi CG, et al. Combined evaluation of regional coronary artery calcium and myocardial perfusion by (82)Rb PET/CT in the identification of obstructive coronary artery disease. Eur J Nucl Med Mol Imaging. 2018;45(4):521–529. doi: 10.1007/s00259-018-3935-1. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous